Easy assay development with TSA-based multiplexed immunofluorescence

Watch Now

December 6 2021

On demand



Multiplex immunofluorescence IHC is a powerful technique to address the increasing research needs in immuno-oncology to understand the tumor microenvironment better. This webinar presents a rapid and automated high-plex fluorescent immunostaining procedure using our microfluidic-based staining device LabSat® Research and TSA staining reagents. The 6-marker protocol could be performed in less than 4 hours and 30 minutes, resulting in high-quality marker detection, efficient removal of antibodies, and remarkable signal uniformity.

December 6, 2021

  • Microfluidic technology & staining solutions
  • Automated TSA-based multiplexing: tonsil optimization
  • Easy protocol transfer to a specific cancer type Case study: NSCLC


Alexandre Kehren

Alexandre Kehren

Application Development Team Leader